Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03998657 · ClinicalTrials.gov registry record · NA

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

A NA study of Prostate Cancer, sponsored by InSightec.

Active
Registry status
NA
Development phase
14
Enrollment target
5
Study locations

NCT03998657: Active NA study of Prostate Cancer, sponsored by InSightec.

NCT03998657 is a NA study of Prostate Cancer that is active but no longer recruiting, run by InSightec. The registered enrollment target is 14 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03998657, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by InSightec.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
5
Study locations

Study Summary

This extended clinical investigation is a multicenter, prospective, single arm study intended to provide continued access of the Exablate Model 2100 device (Exablate Prostate) to patients for treatment of prostate lesions and collect additional safety and effectiveness data during the 510(k) preparation and review period.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE Exablate Prostate Treatment

Study Locations (5)

California

  • Stanford University School of Medicine - Stanford

Florida

  • Sperling Prostate Center - Delray Beach

Massachusetts

  • Brigham & Women's Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

New York

  • Memorial Sloan-Kettering Cancer Center - New York

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2019-12-19
Est. Completion 2026-12-30
Phase NA

Sponsor

InSightec

38 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03998657

The ClinicalTrials.gov registry entry for NCT03998657 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (98% lower). The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Exablate Prostate Treatment is the first listed.

NCT03998657 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03998657 about?

NCT03998657 is a clinical study titled "Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions". This extended clinical investigation is a multicenter, prospective, single arm study intended to provide continued access of the Exablate Model 2100 device (Exablate Prostate) to patients for treatment of prostate lesions and collect additional safety and effectiveness data during the 510(k) prepara...

What is the current status of trial NCT03998657?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2019-12-19. Estimated completion is 2026-12-30.

What conditions does trial NCT03998657 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03998657?

The interventions under investigation include: Exablate Prostate Treatment (DEVICE).

Who is sponsoring clinical trial NCT03998657?

This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03998657 being conducted?

This trial has 5 study locations across California, Florida, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.